Grey Cloak Tech, Inc. (OTCQB: GRCK) this morning announced that it has acquired Eqova Life Sciences, a medically-focused CBD company, in an all-stock transaction. Located in Denver, Colorado, Eqova Life Sciences develops clinical-grade Full Spectrum Hemp Oil products that are sold exclusively via partnerships with licensed medical practitioners. Per the news release, no other hemp oil company currently focuses exclusively on the practitioner market, leaving it largely underserved. Included in the acquisition, Eqova has approximately $150,000 worth of CBD inventory, which is expected to be sold by the end of 2017. Eqova also has hundreds of relationships with suppliers, vendors and medical professionals who can carry their products and dozens of independent sales reps, as well as thousands in sales ready to book to Grey Cloak’s income statement. “Now that we have merged with GRCK, the possibilities for us in the CBD space are endless,” Patrick Stiles, incoming president and CEO of Grey Cloak, stated in the news release. “Eqova will just be the beginning. We will have the flexibility to enter many other segments of the industry.”
Read the full article
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Grey Cloak Tech, Inc. (GRCK) Acquires Eqova Life Sciences
